HCA Healthcare, Inc. income statement
$499.05−0.32%
HCA Healthcare, Inc. reported revenue of $75.6 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 7.1% from fiscal 2024. Net income was $6.78 billion and diluted earnings per share $28.33.
From HCA Healthcare, Inc.'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.
Annual
| USD | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $34.18B | $36.92B | $39.68B | $41.49B | $43.61B | $46.68B | $51.34B | $51.53B | $58.75B | $60.23B | $64.97B | $70.60B | $75.60B | $78.70B |
| Revenue growth | — | — | — | — | — | +8.0% | +7.5% | +4.6% | +5.1% | +7.0% | +10.0% | +0.4% | +14.0% | +2.5% | +7.9% | +8.7% | +7.1% | — |
| Net interest income | — | — | — | — | −$1.85B | −$1.74B | −$1.67B | −$1.71B | −$1.69B | −$1.75B | −$1.82B | — | — | — | — | — | — | — |
| Selling, general and administrative | $164.0M | $182.0M | $228.0M | $248.0M | $287.0M | $285.0M | $327.0M | $343.0M | $340.0M | $344.0M | $370.0M | $416.0M | $337.0M | $307.0M | $353.0M | $421.0M | $548.0M | $580.0M |
| Operating income | $3.99B | $4.33B | $5.60B | $4.69B | $4.79B | $5.22B | $5.62B | $6.52B | $6.07B | $7.07B | $7.24B | $7.25B | $11.30B | $10.35B | $9.62B | $10.56B | $12.00B | $12.12B |
| Operating margin | — | — | — | — | 14.0% | 14.2% | 14.2% | 15.7% | 13.9% | 15.1% | 14.1% | 14.1% | 19.2% | 17.2% | 14.8% | 15.0% | 15.9% | 15.4% |
| Interest expense | $1.99B | $2.10B | $2.04B | $1.80B | $1.85B | $1.74B | $1.67B | $1.71B | $1.69B | $1.75B | $1.82B | $1.58B | $1.57B | $1.74B | $1.94B | $2.06B | $2.25B | $2.36B |
| Income before tax | $2.00B | $2.23B | $3.56B | $2.89B | $2.95B | $3.48B | $3.96B | $4.81B | $4.38B | $5.33B | $5.24B | $5.43B | $9.83B | $8.58B | $7.71B | $8.52B | $9.83B | $9.82B |
| Income tax expense | $627.0M | $658.0M | $719.0M | $888.0M | $950.0M | $1.11B | $1.26B | $1.38B | $1.64B | $946.0M | $1.10B | $1.04B | $2.11B | $1.75B | $1.61B | $1.87B | $2.05B | $2.02B |
| Effective tax rate | 31.3% | 29.5% | 20.2% | 30.7% | 32.2% | 31.8% | 31.9% | 28.6% | 37.4% | 17.7% | 21.0% | 19.2% | 21.5% | 20.3% | 21.0% | 21.9% | 20.9% | 20.6% |
| Net income | $1.05B | $1.21B | $2.46B | $1.60B | $1.56B | $1.88B | $2.13B | $2.89B | $2.22B | $3.79B | $3.50B | $3.75B | $6.96B | $5.64B | $5.24B | $5.76B | $6.78B | $6.78B |
| Net margin | — | — | — | — | 4.6% | 5.1% | 5.4% | 7.0% | 5.1% | 8.1% | 6.8% | 7.3% | 11.8% | 9.4% | 8.1% | 8.2% | 9.0% | 8.6% |
| EPS · diluted | $2.44 | $2.76 | $4.97 | $3.49 | $3.37 | $4.16 | $4.99 | $7.30 | $5.95 | $10.66 | $10.07 | $10.93 | $21.16 | $19.15 | $18.97 | $22.00 | $28.33 | $30.20 |
| Diluted weighted average shares | 432M | 437M | 496M | 459M | 462M | 450M | 427M | 396M | 372M | 355M | 348M | 344M | 329M | 295M | 276M | 262M | 239M | 224M |
| Basic weighted average shares | 426M | 426M | 477M | 440M | 445M | 436M | 414M | 384M | 362M | 347M | 341M | 338M | 323M | 290M | 272M | 259M | 236M | 221M |
| EBITDA | $5.41B | $5.75B | $7.06B | $6.37B | $6.55B | $7.04B | $7.53B | $8.48B | $8.20B | $9.35B | $9.83B | $9.98B | $14.15B | $13.32B | $12.70B | $13.87B | $15.53B | $15.85B |
| EBITDA margin | — | — | — | — | 19.2% | 19.1% | 19.0% | 20.4% | 18.8% | 20.0% | 19.2% | 19.4% | 24.1% | 22.1% | 19.5% | 19.6% | 20.5% | 20.1% |
| Depreciation & amortization | $1.43B | $1.42B | $1.47B | $1.68B | $1.75B | $1.82B | $1.90B | $1.97B | $2.13B | $2.28B | $2.60B | $2.72B | $2.85B | $2.97B | $3.08B | $3.31B | $3.52B | $3.74B |
| Stock-based compensation | $40.00M | $32.00M | $26.00M | $56.00M | $113.0M | $163.0M | $239.0M | $251.0M | $270.0M | $268.0M | $347.0M | $362.0M | $440.0M | $341.0M | $262.0M | $360.0M | $401.0M | $404.0M |
| Dividends per share | — | $9.43 | — | $6.50 | — | — | — | — | — | $1.40 | $1.60 | $1.72 | $1.92 | $2.24 | $2.40 | $2.64 | $2.88 | $3.06 |
Quarterly
| USD | Q4 FY2023 | Q1 FY2024 | Q2 FY2024 | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.30B | $17.34B | $17.49B | $17.49B | $18.29B | $18.32B | $18.61B | $19.16B | $19.51B | $19.11B | $20.23B | $19.85B |
| Selling, general and administrative | $62.00M | $90.00M | $100.0M | $111.0M | $120.0M | $126.0M | $130.0M | $139.0M | $153.0M | $133.0M | $148.0M | $146.0M |
| Operating income | $2.81B | $2.76B | $2.74B | $2.41B | $2.65B | $2.86B | $2.96B | $2.96B | $3.22B | $2.86B | $3.08B | $2.96B |
| Operating margin | 16.2% | 15.9% | 15.7% | 13.8% | 14.5% | 15.6% | 15.9% | 15.5% | 16.5% | 15.0% | 15.2% | 14.9% |
| Interest expense | $491.0M | $512.0M | $506.0M | $515.0M | $528.0M | $547.0M | $568.0M | $561.0M | $572.0M | $584.0M | $599.0M | $607.0M |
| Income before tax | $2.35B | $2.25B | $2.24B | $1.91B | $2.13B | $2.33B | $2.42B | $2.42B | $2.67B | $2.29B | $2.49B | $2.37B |
| Income tax expense | $484.0M | $445.0M | $550.0M | $424.0M | $447.0M | $502.0M | $524.0M | $515.0M | $509.0M | $430.0M | $564.0M | $521.0M |
| Effective tax rate | 20.6% | 19.8% | 24.6% | 22.2% | 21.0% | 21.6% | 21.7% | 21.3% | 19.0% | 18.8% | 22.6% | 22.0% |
| Net income | $1.61B | $1.59B | $1.46B | $1.27B | $1.44B | $1.61B | $1.65B | $1.64B | $1.88B | $1.62B | $1.70B | $1.58B |
| Net margin | 9.3% | 9.2% | 8.4% | 7.3% | 7.9% | 8.8% | 8.9% | 8.6% | 9.6% | 8.5% | 8.4% | 8.0% |
| EPS · diluted | $5.93 | $5.93 | $5.53 | $4.88 | $5.63 | $6.45 | $6.83 | $6.96 | $8.14 | $7.15 | $7.62 | $7.27 |
| Diluted weighted average shares | 271M | 268M | 264M | 260M | 255M | 249M | 242M | 236M | 231M | 227M | 223M | 217M |
| Basic weighted average shares | 267M | 264M | 261M | 257M | 252M | 247M | 239M | 233M | 227M | 224M | 221M | 215M |
| EBITDA | $3.60B | $3.56B | $3.56B | $3.25B | $3.51B | $3.72B | $3.83B | $3.85B | $4.13B | $3.79B | $4.02B | $3.91B |
| EBITDA margin | 20.8% | 20.5% | 20.4% | 18.6% | 19.2% | 20.3% | 20.6% | 20.1% | 21.2% | 19.8% | 19.9% | 19.7% |
| Depreciation & amortization | $789.0M | $795.0M | $819.0M | $842.0M | $856.0M | $860.0M | $863.0M | $889.0M | $911.0M | $930.0M | $944.0M | $954.0M |
| Stock-based compensation | $57.00M | $87.00M | $112.0M | $76.00M | $85.00M | $98.00M | $99.00M | $104.0M | $100.0M | $86.00M | $85.00M | $133.0M |
| Dividends per share | $0.60 | $0.66 | $0.66 | $0.66 | $0.66 | $0.72 | $0.72 | $0.72 | $0.72 | $0.78 | $0.78 | $0.78 |
The main figures as JSON and plain text. See data and methodology.
HCA in the terminal
Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.